Gubra A/S Sustainability Reports

Gubra A/S is a specialized biotechnology company that provides preclinical contract research services (CRO) and conducts advanced peptide-based drug discovery. The company focuses heavily on metabolic and fibrotic diseases such as obesity, diabetes, and MASH.

Sector: Professional & technical services

Country: Denmark

Exchange: Nasdaq Copenhagen

LEI: 254900T17RRFZONO6W53

FIGI: BBG01FZSSTZ3

13 reports from 2019 to 2025

• Gubra A/S 2025 Corporate Governance Statement
• Gubra A/S 2025 Annual Report
• Gubra A/S 2024 Corporate Governance Statement
• Gubra A/S 2024 Sustainability Statement
• Gubra A/S 2024 Annual Report